文献速递胸部CT

既往恶性肿瘤患者中的肺癌筛查:该队列是否面临更高的恶性肿瘤风险?

Lung cancer screening in patients with previous malignancy: Is this cohort at increased risk for malignancy?
PubMed 文献 · Eur Radiol · 2020-07-29

本研究纳入543例有既往恶性肿瘤史、预期寿命≥5年的患者,于2011年5月2日至2018年11月28日转诊行低剂量CT肺癌筛查。筛查CT中17.5%为Lung-RADS阳性结果,35例(6.4%)诊断第二原发肺癌,其中21例为患病率癌、14例为后续筛查轮次检出的 interval 癌。作者认为该人群筛查检出第二原发肺癌率高于历史前瞻性筛查研究报告的普通筛查人群,并提示需前瞻性研究评估死亡率获益。

要点

  • 既往恶性肿瘤患者行LDCT筛查时Lung-RADS阳性率为17.5%,第二原发肺癌检出率为6.4%。
  • 35例第二原发肺癌中21例为患病率癌、14例为后续筛查轮次检出的interval癌。
  • 作者指出该人群筛查检出率高于历史前瞻性随机筛查的普通人群,并建议前瞻性研究评估死亡率获益。

核心结论

  • 有既往恶性肿瘤史患者中筛查检出的第二原发肺癌率高于历史前瞻性筛查研究报道的普通筛查人群。
  • 作者认为需要前瞻性研究评估筛查对该人群是否带来死亡率获益。

研究设计与样本

  • 研究类型为在三级癌症中心低剂量CT肺癌筛查项目中的队列研究,纳入2011年5月2日至2018年11月28日转诊行CT肺癌筛查、有既往恶性肿瘤史且预期寿命≥5年的患者。
  • 共纳入543例患者,平均年龄66岁。
  • 收集吸烟史和既往胸部放疗史等危险因素信息,CT评估结节大小、形态特征和数量。
  • Lung-RADS评分系统对2014年10月前的研究回顾性应用,对其余研究前瞻性应用。

关键影像表现/征象

  • 筛查CT中17.5%按Lung-RADS评分系统为阳性筛查结果。
  • 35例(6.4%)诊断第二原发肺癌,其中21例为患病率癌、14例为后续筛查轮次检出的interval癌。
  • 既往肿瘤类型最常见为乳腺癌205例(38%)、头颈癌105例(19%)、肺癌87例(16%)。

诊断标准与关键数值

  • 采用Lung-RADS评分系统判定筛查结果阳性,阳性筛查结果占17.5%。

临床应用与阅片要点

  • 作者认为该人群筛查检出第二原发肺癌率高于历史前瞻性筛查研究的普通人群,并提示需前瞻性研究评估死亡率获益。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To determine the rate of second primary lung cancer (SPLC) and describe the clinical characteristics and radiological findings in individuals with a prior history of cancer presenting to a low-dose computed tomography (LDCT) lung cancer screening program at a tertiary cancer center.

METHODS: Patients with a previous history of malignancy, a life expectancy ≥ 5 years referred for CT lung cancer screening between May 2, 2011, and November 28, 2018, were included. Demographics regarding risk factors including smoking history and prior history of thoracic radiation were collected. CT scan features assessed nodule size, morphologic features, and number. The Lung-CT Reporting and Data System (Lung-RADS) scoring system was retrospectively applied to studies performed before October 2014 and prospectively applied to remainder of studies. Data was collected in a Health Insurance Portability and Accountability Act (HIPAA)-compliant manner.

RESULTS: A total of 543 patients were studied (mean age of 66 years). All had a previous history of cancer, most commonly breast cancer 205 (38%), head and neck cancer 105 (19%), and lung cancer 87 (16%). Of screening CTs performed, 17.5% were positive screening study results as per Lung-RADS scoring system. SPLC was diagnosed in 35 patients (6.4%) with 21 prevalence cancers detected and 14 interval cancers detected in subsequent screening rounds.

CONCLUSIONS: The rate of screen-detected SPLC in patients with prior malignancy is higher than reported rates seen in historical prospective screening studies. Our study suggests the need for prospective research to evaluate any mortality benefit that screening may have in this population.

KEY POINTS: • The rate of screen-detected second primary lung cancer in patients with prior malignancy is higher than reported rates seen in historical prospective randomized lung cancer screening studies in a general screened population. • Patients with a prior malignancy undergoing lung cancer screening have higher rates of positive screening studies and higher rates of invasive diagnostic procedures than those reported in a general screening population. • Prospective research is required to evaluate if screening offers a mortality benefit in this population.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. O'Dwyer E, Halpenny DF, Ginsberg MS, et al. Lung cancer screening in patients with previous malignancy: Is this cohort at increased risk for malignancy? Eur Radiol. 2020. PMID: 32728771. doi:10.1007/s00330-020-07026-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。